Changes in brain tissue oxygenation after treatment of diffuse traumatic brain injury by erythropoietin

Critical Care Medicine

Volumn 41, Issue 5, 2013, Pages 1316-1324

  Bouzat, Pierre ^a,b,c   Millet, Anne ^a,b,d   Boue, Yvonnick ^a,b,c   Pernet Gallay, Karin ^a,b   Trouve Buisson, Thibaut ^a,b,c   Gaide Chevronnay, Lucie ^a,b,c   Barbier, Emmanuel L ^a,b   Payen, Jean Francois ^a,b,c  

^a GRENOBLE INSTITUT DES NEUROSCIENCES   (France)

^b UNIV GRENOBLE ALPES   (France)

^c HÔPITAL MICHALLON   (France)

^d Hôpital Couple Enfant   (France)

Author keywords

BOLD; brain edema; brain oxygenation; erythropoietin; MR diffusion weighted imaging; MRI; traumatic brain injury

Indexed keywords

HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PH; ARTICLE; BOLD SIGNAL; BRAIN; BRAIN BLOOD VOLUME; BRAIN EDEMA; BRAIN PERFUSION; DIFFUSION WEIGHTED IMAGING; MALE; NEOCORTEX; NONHUMAN; OXYGEN SATURATION; OXYGENATION; PRIORITY JOURNAL; RAT; TRAUMATIC BRAIN INJURY;

ANIMALS; BRAIN; BRAIN EDEMA; BRAIN INJURIES; BRAIN ISCHEMIA; CEREBROVASCULAR CIRCULATION; DIFFUSION MAGNETIC RESONANCE IMAGING; DISEASE MODELS, ANIMAL; ERYTHROPOIETIN; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MICROCIRCULATION; OXYGEN CONSUMPTION; RANDOM ALLOCATION; RATS; RATS, WISTAR; REFERENCE VALUES; RISK FACTORS;

EID: 84876585858     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31827ca64e     Document Type: Article

References (47)

1. Bratton SL, Chestnut RM, Ghajar J, et al: Guidelines for the management of severe traumatic brain injury. IX. Cerebral perfusion thresholds. J Neurotrauma 2007; 24(Suppl 1):S59-64
2. Chang JJ, Youn TS, Benson D, et al: Physiologic and functional outcome correlates of brain tissue hypoxia in traumatic brain injury. Crit Care Med 2009; 37:283-290
3. Oddo M, Levine JM, Mackenzie L, et al: Brain hypoxia is associated with short-term outcome after severe traumatic brain injury independently of intracranial hypertension and low cerebral perfusion pressure. Neurosurgery 2011; 69:1037-45; discussion 1045
4. Stiefel MF, Spiotta A, Gracias VH, et al: Reduced mortality rate in patients with severe traumatic brain injury treated with brain tissue oxygen monitoring. J Neurosurg 2005; 103:805-811
5. Narotam PK, Morrison J F, Nathoo N: Brain tissue oxygen monitoring in traumatic brain injury and major trauma: outcome analysis of a brain tissue oxygen-directed therapy. J Neurosurg 2009; 111:672-682
6. Rosenthal G, Hemphill JC III, Sorani M, et al: Brain tissue oxygen tension is more indicative of oxygen diffusion than oxygen delivery and metabolism in patients with traumatic brain injury. Crit Care Med 2008; 36:1917-1924
7. Masamoto K, Tanishita K: Oxygen transport in brain tissue. J Biomech Eng 2009; 131:074002
8. Jespersen SN, Østergaard L: The roles of cerebral blood fow, capillary transit time heterogeneity, and oxygen tension in brain oxygenation and metabolism. J Cereb Blood Flow Metab 2012; 32:264-277
9. Vaz R, Sarmento A, Borges N, et al: Ultrastructural study of brain microvessels in patients with traumatic cerebral contusions. Acta Neurochir (Wien) 1997; 139:215-220
10. Rodríguez-Baeza A, Reina-de la Torre F, Poca A, et al: Morphological features in human cortical brain microvessels after head injury: a three-dimensional and immunocytochemical study. Anat Rec A Dis-cov Mol Cell Evol Biol 2003; 273:583-593
11. Bullock R, Maxwell WL, Graham DI, et al: Glial swelling following human cerebral contusion: an ultrastructural study. J Neurol Neuro-surg Psychiatr 1991; 54:427-434
12. Dietrich WD, Alonso O, Halley M: Early microvascular and neuronal consequences of traumatic brain injury: a light and electron microscopic study in rats. J Neurotrauma 1994; 11:289-301
13. Schwarzmaier SM, Kim SW, Trabold R, et al: Temporal profle of thrombogenesis in the cerebral microcirculation after traumatic brain injury in mice. J Neurotrauma 2010; 27:121-130
14. Menon DK, Coles JP, Gupta AK, et al: Diffusion limited oxygen delivery following head injury. Crit Care Med 2004; 32:1384-1390
15. nd cerebral protection after acute injuries: a double-edged sword? Pharmacol Ther 2010; 128:445-459
16. Ponce LL, Navarro JC, Ahmed O, et al: Erythropoietin neuroprotec-tion with traumatic brain injury. Pathophysiology 2012 Mar 13. [Epub ahead of print] doi.org/10.1016/j.pathophys.2012.02.005
17. Yatsiv I, Grigoriadis N, Simeonidou C, et al: Erythropoietin is neuro-protective, improves functional recovery, and reduces neuronal apop-tosis and infammation in a rodent model of experimental closed head injury. FASEB J 2005; 19:1701-1703
18. Robertson CS, Garcia R, Gaddam SS, et al: Treatment of mild traumatic brain injury with an erythropoietin-mimetic peptide. J Neu-rotrauma 2012; doi:10.1089/neu.2012.2431
19. Verdonck O, Lahrech H, Francony G, et al: Erythropoietin protects from post-traumatic edema in the rat brain. J Cereb Blood Flow Metab 2007; 27:1369-1376
20. Bouzat P, Francony G, Thomas S, et al: Reduced brain edema and functional defcits after treatment of diffuse traumatic brain injury by carbamylated erythropoietin derivative. Crit Care Med 2011; 39:2099-2105
21. Xiong Y, Mahmood A, Qu C, et al: Erythropoietin improves histologi-cal and functional outcomes after traumatic brain injury in mice in the absence of the neural erythropoietin receptor. J Neurotrauma 2010; 27:205-215
22. Cherian L, Goodman JC, Robertson C: Neuroprotection with eryth-ropoietin administration following controlled cortical impact injury in rats. J Pharmacol Exp Ther 2007; 322:789-794
23. Marmarou A, Foda MA, van den Brink W, et al: A new model of diffuse brain injury in rats. Part I: Pathophysiology and biomechanics. J Neurosurg 1994; 80:291-300
24. Christen T, Lemasson B, Pannetier N, et al: Evaluation of a quantitative blood oxygenation level-dependent (qBOLD) approach to map local blood oxygen saturation. NMR Biomed 2011; 24:393-403
25. Barbier EL, Lamalle L, Décorps M: Methodology of brain perfusion imaging. J Magn Reson Imaging 2001; 13:496-520
26. Troprès I, Grimault S, Vaeth A, et al: Vessel size imaging. Magn Reson Med 2001; 45:397-408
27. Lemasson B, Christen T, Tizon X, et al: Assessment of multiparametric MRI in a human glioma model to monitor cytotoxic and anti-angio-genic drug effects. NMR Biomed 2011; 24:473-482
28. Christen T, Zaharchuk G, Pannetier N, et al: Quantitative MR estimates of blood oxygenation based on T2*: a numerical study of the impact of model assumptions. Magn Reson Med 2012; 67:1458-1468
29. Spees WM, Yablonskiy DA, Oswood MC, et al: Water proton MR properties of human blood at 1.5 Tesla: magnetic susceptibility, T(1), T(2), T*(2), and non-Lorentzian signal behavior. Magn Reson Med 2001; 45:533-542
30. He X, Yablonskiy DA: Quantitative BOLD: mapping of human cerebral deoxygenated blood volume and oxygen extraction fraction: default state. Magn Reson Med 2007; 57:115-126
31. An H, Liu Q, Chen Y, et al: Evaluation of MR-derived cerebral oxygen metabolic index in experimental hyperoxic hypercapnia, hypoxia, and ischemia. Stroke 2009; 40: 2165-2172
32. Christen T, Lemasson B, Pannetier N, et al: Is T2* enough to assess oxygenation? Quantitative blood oxygen level-dependent analysis in brain tumor. Radiology 2012; 262:495-502
33. Valable S, Lemasson B, Farion R, et al: Assessment of blood volume, vessel size, and the expression of angiogenic factors in two rat glioma models: a longitudinal in vivo and ex vivo study. NMR Biomed 2008; 21:1043-1056
34. Johnston AJ, Steiner LA, Coles JP, et al: Effect of cerebral perfusion pressure augmentation on regional oxygenation and metabolism after head injury. Crit Care Med 2005; 33:189-95; discussion 255
35. Shimosegawa E, Hatazawa J, Ibaraki M, et al: Metabolic penumbra of acute brain infarction: a correlation with infarct growth. Ann Neurol 2005; 57:495-504
36. Menon DK: Procrustes, the traumatic penumbra, and perfusion pressure targets in closed head injury. Anesthesiology 2003; 98:805-807
37. Abate MG, Trivedi M, Fryer TD, et al: Early derangements in oxygen and glucose metabolism following head injury: the ischemic penumbra and pathophysiological heterogeneity. Neurocrit Care 2008; 9:319-325
38. Valable S, Francony G, Bouzat P, et al: The impact of erythropoietin on short-term changes in phosphorylation of brain protein kinases in a rat model of traumatic brain injury. J Cereb Blood Flow Metab 2010; 30:361-369
39. Sakowitz OW, Stover JF, Sarrafzadeh AS, et al: Effects of mannitol bolus administration on intracranial pressure, cerebral extracellular metabolites, and tissue oxygenation in severely head-injured patients. J Trauma 2007; 62:292-298
40. Francony G, Fauvage B, Falcon D, et al: Equimolar doses of mannitol and hypertonic saline in the treatment of increased intracranial pressure. Crit Care Med 2008; 36:795-800
41. Diringer MN, Scalfani MT, Zazulia AR, et al: Cerebral hemodynamic and metabolic effects of equi-osmolar doses mannitol and 23.4% saline in patients with edema following large ischemic stroke. Neuro-crit Care 2011; 14:11-17
42. Moriyama M, Jayakumar AR, Tong XY, et al: Role of mitogen-activated protein kinases in the mechanism of oxidant-induced cell swelling in cultured astrocytes. J Neurosci Res 2010; 88:2450-2458
43. Rao KV, Jayakumar AR, Reddy PV, et al: Aquaporin-4 in manganese-treated cultured astrocytes. Glia 2010; 58:1490-1499
44. Kilic E, Kilic U, Soliz J, et al: Brain-derived erythropoietin protects from focal cerebral ischemia by dual activation of ERK-1/-2 and Akt pathways. FASEB J 2005; 19:2026-2028
45. Kroppenstedt SN, Thomale UW, Griebenow M, et al: Effects of early and late intravenous norepinephrine infusion on cerebral perfusion, microcirculation, brain-tissue oxygenation, and edema formation in brain-injured rats. Crit Care Med 2003; 31:2211-2221
46. Lifshitz J, Sullivan PG, Hovda DA, et al: Mitochondrial damage and dysfunction in traumatic brain injury. Mitochondrion 2004; 4: 705-713
47. Gunnarson E, Song Y, Kowalewski JM, et al: Erythropoietin modulation of astrocyte water permeability as a component of neuroprotec-tion. Proc Natl Acad Sci USA 2009; 106:1602-1607